The graphic below is a representation of the organizational chart of the Contract Development and Manufacturing Organization. If you need the information depicted by this graphic in another format, please email us at mitchell-rotman@uiowa.edu.
EXECUTIVE COMMITTEE
The CBB Executive Committee is composed of representatives from eight university departments. It is the primary policy-making group of the CBB and meets regularly to discuss and advise on budgets as well as research and educational programs. CBB members in their respective departments elect representatives of the Executive Committee annually and they may serve a three-year period or more.
| Current CBB Executive Committee | ||
|
Faculty Member |
Department |
|
|
Mark Arnold (Chair),
|
Chemistry/Director, Center for Biocatlaysis and Bioprocessing
|
|
|
Christopher Ahern, Ph.D., Professor
|
Molecular Physics and Biosciences
|
|
|
Jennifer Fiegel, Ph.D., Professor
|
Chemical and Biochemical Engineering
|
|
|
Robert Kerns, Ph.D., Professor
|
Pharmaceutical Sciences and Experimental Therapeutics
|
|
|
Michael Schnieders, D.Sc., Associate Professor
Maria Spies, Ph.D., Professor
|
Biochemistry, Biomedical Engineering
Biochemistry and Molecular Biology
|
|
|
Munir Tanas, Ph.D. Associate Professor
|
Pathology
|
|
| Florence Williams, Ph.D., Assistant Professor |
Chemistry
|
|
EXTERNAL ADVISORY BOARD
The CBB Advisory Board consists of distinguished academic and industrial scientists representing agrochemical, pharmaceutical, chemical and biotechnology industry. Board members attend the annual CBB conference to discuss the direction of the Center, its programs, and offer insights into ways the Center can best interact with industries through technology transfer. Board members also recommend topics for the annual conference, and sometimes serve as speakers.
| Advisory Board | |
| Board Members | Affiliation |
| Charles Abbas, Ph.D. | Founder and CTO at ibiocat |
| Mark A. Behlke, M.D., Ph.D. | Chief Scientific Officer, Integrated DNA Technologies, Inc. |
| Peter Mueller, Ph.D. |
President and Founder of the Mueller Health Foundation and Chairman of BioXcel Therapeutics, Inc. and Chairman of BioXcell Therapeutics, Inc. |
| Laura Shawver, Ph.D. | President, CEO and Director, Capstan Therapeutics |
| Past Board Members | |
| Affiliation - current at time of posting and may not reflect their current position/affiliation | |
| Thomas Binder | President, ADM Research Division Archer Daniel Midland Company |
| Douglas Cameron | Chief Scientist, Biotechnology Development Center, Cargill Inc. |
| Arnold Demain | Charles A Dana Research Institute, Drew University, National Academy of SciencesMember |
| Robert DiCosimo | Senior Research Fellow, DuPont Central Research and Development |
| Mervyn de Souza | Director of Technology and Innovation, BioPharma and Savory Flavors, Sensient Technologies |
| Randolph Greasham | Director of Process Research, Merck |
| Steven J. Gould | Chief Scientific Officer, Mera Pharmaceuticals |
| Lorenz Hasler | Senior Project Evaluation Manager, Globial Biological Operations, Lonza AG |
| T. Kent Kirk | Forest Products Fed Res. Labs, Dept Bacteriology, University of Wisconsin, Madison, Member National Academy of Sciences |
| Hans Leuenberger | Deputy Director, Central Research, Hoffmann LaRoche |
| Ashwin Madia | Vice President for Biotechnology research, Cargill |
| Barry Marrs | Director of Biotechnology, Hercules |
| Ellen L. McCormick | Director, Pfizer Global Biologics |
| Saul Neidleman | Neidleman Consulting |
| Peder Holk Nielsen | Corporate Vice president for Enzyme Development & Industrial Biotechnology, Novo Nordisk |
| Ramesh N. Patel | Process Research and Development, Bristol Myers Squibb |
| Nancy Platt | Vice President for Research, Pioneer HiBred |
| Rolland Poust | Director, Pharmaceutical Service, The University of Iowa |
| Karl Sanford | Vice President for Technology Development, Genencor International |
| Jim Spain | Air Force Research Laboratory, MLQL, Tyndall Air Force Base |
| Mani Subramanian | Director, Biotechnology Division, Dow Chemical Company |
| Tim Tressel | Director, Process and Analytical Sciences, Amgen, Inc. |
| Susan Truesdell | Central Research and Development, Pfizer Inc. |
| Mickey Wells | Director, Pharmaceutical Service, The University of Iowa |
| James F White | Senior Research Associate, Engelhard Corporation |
| Gregg Whited | Genencor International |
| Vincent Witterholt | Fellow and Distinguished Scientist, DuPont |
| Richard Whitaker | Pharma/Biotech Consultant |
| Debbie Yaver | Director, Novozymes, Inc. |
| Milton Zmijewski |
Head, Biocatalysis Research, Eli Lilly |